Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ASMB — Assembly Biosciences, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to ASMB Full portfolio

Position in ASMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$800,437
+$572,434 QoQ
Shares Held
29,128
+334.5% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 92 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ASMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ASMB ranks #239 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in ASMB

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $800,437 29,128
2025-12-31 $228,003 6,704
2023-12-31 $26,610 32,452
2023-09-30 $28,882 32,452
2023-06-30 $37,319 32,452
2023-03-31 $27,259 32,452
2022-12-31 $42,187 32,452
2022-09-30 $53,221 32,452
2022-06-30 $68,149 32,452
2022-03-31 $105,818 51,368
2021-06-30 $752,898 194,046
2021-03-31 $1,024,516 222,721
2020-12-31 $1,298,457 214,621
2020-09-30 $3,851,431 234,272
2020-06-30 $4,922,292 211,076
2020-03-31 $2,720,874 183,471